Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Please try another search
The International Monetary Fund downgrades its global growth forecast to 3.5% from 3.7% in its October outlook.The negative revision is partly due to the negative impact of U.S. and China tariff...
Altimmune Inc. (NASDAQ:ALT) has announced positive outcomes from its MOMENTUM Phase II obesity trial for pemvidutide, showing significant weight loss and improvements in health markers. The drug...
Instrument Type
Region
Sector
Industry
Date
Category
Provider